|
|
| Finding and contracting CDMOs who are ready, willing, and able can present challenges for sponsor companies who are developing and manufacturing a novel therapeutic. Outsourced Pharma is helping address these difficulties. The Outsourced Pharma Capacity Update (OPCU) brings together the industry’s leading CDMOs to present real-time and direct information on their available capacity and services, as well as provide specific facility and equipment news. Discover the May 2024 event’s Small Molecule and Fill/Finish presenting sponsors in this newsletter and learn how they are best suited to help you to navigate the path to approval and commercialization. The OPCU offers a unique forum where you can connect with the CDMOs suited for your project’s needs, all from the comfort of your desk. Find the right development and manufacturing partner at the upcoming OPCU in July 2024. Registration is free at the links below. - Monday, July 22, 2024 - Fill/Finish
- Tuesday, July 23, 2024 - Large Molecule Development
- Wednesday, July 24, 2024 - Small Molecule API & HPAPI Development
- Wednesday, July 24, 2024 - Small Molecule Finished Dosage Form
- Thursday, July 25, 2024 - Cell & Gene Therapy
|
|
|
|
INCOG BioPharma Services | INCOG has been designed and built to deliver better CDMO services in the injectable drug product space. Gain an overview and update of our expanding capabilities with an inside look at our facility. | Request Information | INCOG BioPharma Services |
|
|
Pfizer CentreOne | Senior Business Development Manager, Christine Rodi, highlights our overall sterile injectable drug substance capabilities, with a focus on our ability to help meet your complex sterile injectable needs. | Request Information | Pfizer CentreOne |
|
|
Alcami | Alcami offers sterile drug product fill finish services including formulation development, complex formulations, clinical manufacturing, batch scale-up, and commercial manufacturing. | Request Information | Alcami |
|
|
PCI Pharma Services | Review our global sterile fill-finish and lyophilization capabilities, capacities, and how strategic investments allow us to meet the growing need for expert sterile development and manufacturing. | Request Information | PCI Pharma Services |
|
|
SMALL MOLECULE API & HPAPI DEVELOPMENT |
|
|
Lonza | With 37 cGMP mills of different sizes and types, and dedicated areas for steroids, HPAPIs, and even cryogenic milling, our Monteggio site is well-equipped to support a wide range of projects. | Request Information | Lonza |
|
|
Adare Pharma Solutions | A partner with services from the earliest phases of development and formulation to manufacturing and packaging is critical for advancing your product to market with reduced cost and time. | Request Information | Adare Pharma Solutions |
|
|
Ajinomoto Bio-Pharma Services | In this presentation, our experts delve into the advancements in our development and manufacturing capabilities for HPAPI, clinical development, and late stage projects. | Request Information | Ajinomoto Bio-Pharma Services |
|
|
MilliporeSigma | Our small molecule API CDMO team has the expertise, experience, and specialized facilities to make our customers' small molecule API projects a success. | Request Information | MilliporeSigma |
|
|
SMALL MOLECULE FINISHED DOSAGE FORM |
|
|
Pfizer CentreOne | We offer a wide range of OSD platform manufacturing and packaging formats. Our services are designed to help provide the optimum balance between customization and effective and reliable supply. | Request Information | Pfizer CentreOne |
|
|
Alcami | We offer OSD development, solid-state characterization, clinical manufacturing, batch scale-up, and commercial manufacturing. We also offer packaging services designed to meet commercial needs. | Request Information | Alcami |
|
|
PCI Pharma Services | Learn how recent investments have greatly increased our available capacity for the development, manufacture, and packaging of highly potent drug products, including solid oral and liquid dosage forms. | Request Information | PCI Pharma Services |
|
|
|
|
| Streamline your search for the ideal CDMO partner at the July 2024 OPCU virtual event! Registration is open now, offering you the opportunity to connect with numerous CDMOs in a single day and avoid the hassle of an extended vetting process. For your convenience, OPCU is grouped by molecule type. You can register for the session(s) highlighting the CDMOs equipped to meet your company's development and manufacturing needs. - Monday, July 22, 2024 - Fill/Finish | Free Registration
- Tuesday, Jult 23, 2024 - Large Molecule Development | Free Registration
- Wednesday, July 24, 2024 - Small Molecule API & HPAPI Development | Free Registration
- Wednesday, July 24, 2024 - Small Molecule Finished Dosage Form | Free Registration
- Thursday, July 25, 2024 - Cell & Gene Therapy | Free Registration
|
|
|
